Global Diabetes Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Diabetes Drug

• 1.1 Definition of Diabetes Drug
• 1.2 Diabetes Drug Segment by Type
  • 1.2.1 Global Diabetes Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Insulin
  • 1.2.3 Sensitizers
  • 1.2.4 SGLT-2 Inhibitors
  • 1.2.5 Alpha-glucosidase Inhibitors
  • 1.2.6 Secretagogues
  • 1.2.7 Peptide Analogs
  • 1.2.8 Others
• 1.3 Diabetes Drug Segment by Applications
  • 1.3.1 Global Diabetes Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Diabetes Drug Overall Market
  • 1.4.1 Global Diabetes Drug Revenue (2014-2025)
  • 1.4.2 Global Diabetes Drug Production (2014-2025)
  • 1.4.3 North America Diabetes Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Diabetes Drug Status and Prospect (2014-2025)
  • 1.4.5 China Diabetes Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Diabetes Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Diabetes Drug Status and Prospect (2014-2025)
  • 1.4.8 India Diabetes Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Diabetes Drug
• 2.3 Manufacturing Process Analysis of Diabetes Drug
• 2.4 Industry Chain Structure of Diabetes Drug

3 Development and Manufacturing Plants Analysis of Diabetes Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Diabetes Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Diabetes Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Diabetes Drug Production and Capacity Analysis
• 4.2 Diabetes Drug Revenue Analysis
• 4.3 Diabetes Drug Price Analysis
• 4.4 Market Concentration Degree

5 Diabetes Drug Regional Market Analysis

• 5.1 Diabetes Drug Production by Regions
  • 5.1.1 Global Diabetes Drug Production by Regions
  • 5.1.2 Global Diabetes Drug Revenue by Regions
• 5.2 Diabetes Drug Consumption by Regions
• 5.3 North America Diabetes Drug Market Analysis
  • 5.3.1 North America Diabetes Drug Production
  • 5.3.2 North America Diabetes Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Diabetes Drug Import and Export
• 5.4 Europe Diabetes Drug Market Analysis
  • 5.4.1 Europe Diabetes Drug Production
  • 5.4.2 Europe Diabetes Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Diabetes Drug Import and Export
• 5.5 China Diabetes Drug Market Analysis
  • 5.5.1 China Diabetes Drug Production
  • 5.5.2 China Diabetes Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Diabetes Drug Import and Export
• 5.6 Japan Diabetes Drug Market Analysis
  • 5.6.1 Japan Diabetes Drug Production
  • 5.6.2 Japan Diabetes Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Diabetes Drug Import and Export
• 5.7 Southeast Asia Diabetes Drug Market Analysis
  • 5.7.1 Southeast Asia Diabetes Drug Production
  • 5.7.2 Southeast Asia Diabetes Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Diabetes Drug Import and Export
• 5.8 India Diabetes Drug Market Analysis
  • 5.8.1 India Diabetes Drug Production
  • 5.8.2 India Diabetes Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Diabetes Drug Import and Export

6 Diabetes Drug Segment Market Analysis (by Type)

• 6.1 Global Diabetes Drug Production by Type
• 6.2 Global Diabetes Drug Revenue by Type
• 6.3 Diabetes Drug Price by Type

7 Diabetes Drug Segment Market Analysis (by Application)

• 7.1 Global Diabetes Drug Consumption by Application
• 7.2 Global Diabetes Drug Consumption Market Share by Application (2014-2019)

8 Diabetes Drug Major Manufacturers Analysis

• 8.1 Eli Lilly
  • 8.1.1 Eli Lilly Diabetes Drug Production Sites and Area Served
  • 8.1.2 Eli Lilly Product Introduction, Application and Specification
  • 8.1.3 Eli Lilly Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Novo Nordisk
  • 8.2.1 Novo Nordisk Diabetes Drug Production Sites and Area Served
  • 8.2.2 Novo Nordisk Product Introduction, Application and Specification
  • 8.2.3 Novo Nordisk Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Abbott
  • 8.3.1 Abbott Diabetes Drug Production Sites and Area Served
  • 8.3.2 Abbott Product Introduction, Application and Specification
  • 8.3.3 Abbott Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 AstraZeneca
  • 8.4.1 AstraZeneca Diabetes Drug Production Sites and Area Served
  • 8.4.2 AstraZeneca Product Introduction, Application and Specification
  • 8.4.3 AstraZeneca Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Biocon
  • 8.5.1 Biocon Diabetes Drug Production Sites and Area Served
  • 8.5.2 Biocon Product Introduction, Application and Specification
  • 8.5.3 Biocon Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Sunpharma
  • 8.6.1 Sunpharma Diabetes Drug Production Sites and Area Served
  • 8.6.2 Sunpharma Product Introduction, Application and Specification
  • 8.6.3 Sunpharma Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Sanofi
  • 8.7.1 Sanofi Diabetes Drug Production Sites and Area Served
  • 8.7.2 Sanofi Product Introduction, Application and Specification
  • 8.7.3 Sanofi Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Novartis
  • 8.8.1 Novartis Diabetes Drug Production Sites and Area Served
  • 8.8.2 Novartis Product Introduction, Application and Specification
  • 8.8.3 Novartis Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Merck
  • 8.9.1 Merck Diabetes Drug Production Sites and Area Served
  • 8.9.2 Merck Product Introduction, Application and Specification
  • 8.9.3 Merck Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Pfizer
  • 8.10.1 Pfizer Diabetes Drug Production Sites and Area Served
  • 8.10.2 Pfizer Product Introduction, Application and Specification
  • 8.10.3 Pfizer Diabetes Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Daiichi Sankyo
• 8.12 Boehringer Ingelheim
• 8.13 Akros Pharma
• 8.14 Amgen
• 8.15 Adocia
• 8.16 Peptron
• 8.17 Takeda

9 Development Trend of Analysis of Diabetes Drug Market

• 9.1 Global Diabetes Drug Market Trend Analysis
  • 9.1.1 Global Diabetes Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Diabetes Drug Regional Market Trend
  • 9.2.1 North America Diabetes Drug Forecast 2019-2025
  • 9.2.2 Europe Diabetes Drug Forecast 2019-2025
  • 9.2.3 China Diabetes Drug Forecast 2019-2025
  • 9.2.4 Japan Diabetes Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Diabetes Drug Forecast 2019-2025
  • 9.2.6 India Diabetes Drug Forecast 2019-2025
• 9.3 Diabetes Drug Market Trend (Product Type)
• 9.4 Diabetes Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Diabetes Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List